Verofilcon A contact lenses
DeviceInvestigational daily disposable soft contact lenses
Other names: DDT2
NCT Number: NCT03888469
The purpose of this study was to evaluate visual acuity at distance when wearing DDT2 contact lenses compared to Acuvue Moist contact lenses.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Alcon Investigative Site, Jacksonville, Florida, United States
Subjects were expected to attend 3 study visits and wear study lenses for approximately 14 - 20 days (7 - 10 days for each product).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Key Inclusion Criteria:
Key Exclusion Criteria:
Investigational daily disposable soft contact lenses
Other names: DDT2
Commercially available daily disposable soft contact lenses
Other names: 1DAVM, 1-DAY ACUVUE® MOIST
Time frame: Day 8, each product
Visual acuity was assessed and collected for each eye separately using logarithmic of the Minimum Angle of Resolution (logMAR) charts. A logMAR acuity of 0.0 corresponds to 20/20 Snellen acuity (normal visual acuity), with a negative value denoting better than 20/20 visual acuity.
Alcon Research
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03888482
Eye Diseases, Myopia
Jacksonville, Florida, United States
View Trial DetailsNCT00708032
Eye Diseases, Myopia
Manchester, Greater Manchester, United Kingdom
View Trial DetailsNCT01250925
Eye Diseases, Myopia
Iowa City, Iowa, United States
View Trial DetailsNCT02252133
Eye Diseases, Myopia
Tokyo, Japan
View Trial Details